BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 22273477)

  • 21. Recurrent high-grade cervical lesion after primary conization is associated with persistent human papillomavirus infection in Norway.
    Vintermyr OK; Iversen O; Thoresen S; Quint W; Molijn A; de Souza S; Rosillon D; Holl K
    Gynecol Oncol; 2014 May; 133(2):159-66. PubMed ID: 24631451
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Methylation of HPV18, HPV31, and HPV45 genomes and cervical intraepithelial neoplasia grade 3.
    Wentzensen N; Sun C; Ghosh A; Kinney W; Mirabello L; Wacholder S; Shaber R; LaMere B; Clarke M; Lorincz AT; Castle PE; Schiffman M; Burk RD
    J Natl Cancer Inst; 2012 Nov; 104(22):1738-49. PubMed ID: 23093560
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of careHPV, Cervista Human Papillomavirus, and Hybrid Capture 2 Methods in Diagnosing Cervical Intraepithelial Neoplasia Grade 2+ in Xinjiang Uyghur Women.
    Tuerxun G; Yukesaier A; Lu L; Aierken K; Mijiti P; Jiang Y; Abulizi A; Zhang Y; Abuduxikuer G; Abulizi G; Li H
    Oncologist; 2016 Jul; 21(7):825-31. PubMed ID: 27317575
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human papillomavirus genotype distribution in cervical intraepithelial neoplasia grades 1 or worse among 4215 Chinese women in a population-based study.
    Zhang R; Velicer C; Chen W; Liaw KL; Wu EQ; Liu B; Cui JF; Belinson JL; Zhang X; Shen GH; Chen F; Qiao YL
    Cancer Epidemiol; 2013 Dec; 37(6):939-45. PubMed ID: 24210584
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Attributing oncogenic human papillomavirus genotypes to high-grade cervical neoplasia: which type causes the lesion?
    van der Marel J; Berkhof J; Ordi J; Torné A; Del Pino M; van Baars R; Schiffman M; Wentzensen N; Jenkins D; Quint WG
    Am J Surg Pathol; 2015 Apr; 39(4):496-504. PubMed ID: 25353286
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Roles of extended human papillomavirus genotyping and multiple infections in early detection of cervical precancer and cancer and HPV vaccination.
    Song F; Yan P; Huang X; Wang C; Du H; Qu X; Wu R
    BMC Cancer; 2022 Jan; 22(1):42. PubMed ID: 34991494
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term risk of cervical intraepithelial neoplasia grade 3 or worse according to high-risk human papillomavirus genotype and semi-quantitative viral load among 33,288 women with normal cervical cytology.
    Thomsen LT; Frederiksen K; Munk C; Junge J; Iftner T; Kjaer SK
    Int J Cancer; 2015 Jul; 137(1):193-203. PubMed ID: 25471319
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chromosomal gains and losses in human papillomavirus-associated neoplasia of the lower genital tract - a systematic review and meta-analysis.
    Thomas LK; Bermejo JL; Vinokurova S; Jensen K; Bierkens M; Steenbergen R; Bergmann M; von Knebel Doeberitz M; Reuschenbach M
    Eur J Cancer; 2014 Jan; 50(1):85-98. PubMed ID: 24054023
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human papillomavirus genotype in cervical intraepithelial neoplasia grades 2 and 3 of Taiwanese women.
    Chao A; Jao MS; Huang CC; Huang HJ; Cheng HH; Yang JE; Hsueh S; Chen TC; Qiu JT; Lin CT; Fu CJ; Chou HH; Lai CH
    Int J Cancer; 2011 Feb; 128(3):653-9. PubMed ID: 20473874
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of Human Papillomavirus Genotypes Among Women With High-Grade Cervical Lesions in Beijing, China.
    Xiao M; Xu Q; Li H; Gao H; Bie Y; Zhang Z
    Medicine (Baltimore); 2016 Jan; 95(3):e2555. PubMed ID: 26817906
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term absolute risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: role of persistence.
    Kjær SK; Frederiksen K; Munk C; Iftner T
    J Natl Cancer Inst; 2010 Oct; 102(19):1478-88. PubMed ID: 20841605
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Attribution of human papillomavirus types to cervical intraepithelial neoplasia and invasive cancers in Southern China.
    Chan PK; Cheung TH; Li WH; Yu MY; Chan MY; Yim SF; Ho WC; Yeung AC; Ho KM; Ng HK
    Int J Cancer; 2012 Aug; 131(3):692-705. PubMed ID: 21976212
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differences in human papillomavirus type distribution in high-grade cervical intraepithelial neoplasia and invasive cervical cancer in Europe.
    Tjalma WA; Fiander A; Reich O; Powell N; Nowakowski AM; Kirschner B; Koiss R; O'Leary J; Joura EA; Rosenlund M; Colau B; Schledermann D; Kukk K; Damaskou V; Repanti M; Vladareanu R; Kolomiets L; Savicheva A; Shipitsyna E; Ordi J; Molijn A; Quint W; Raillard A; Rosillon D; De Souza SC; Jenkins D; Holl K;
    Int J Cancer; 2013 Feb; 132(4):854-67. PubMed ID: 22752992
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Methylation analysis of the FAM19A4 gene in cervical scrapes is highly efficient in detecting cervical carcinomas and advanced CIN2/3 lesions.
    De Strooper LM; Meijer CJ; Berkhof J; Hesselink AT; Snijders PJ; Steenbergen RD; Heideman DA
    Cancer Prev Res (Phila); 2014 Dec; 7(12):1251-7. PubMed ID: 25281488
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HPV genotype distribution according to severity of cervical neoplasia.
    Sjoeborg KD; Tropé A; Lie AK; Jonassen CM; Steinbakk M; Hansen M; Jacobsen MB; Cuschieri K; Eskild A
    Gynecol Oncol; 2010 Jul; 118(1):29-34. PubMed ID: 20406711
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Numerical aberrations of chromosome 1 in cervical intraepithelial neoplasia are strongly associated with infection with high-risk human papillomavirus types.
    Bulten J; Melchers WJ; Kooy-Smits MM; de Wilde PC; Poddighe PJ; Robben JC; Macville MV; Massuger LF; Bakkers JM; Hanselaar AG
    J Pathol; 2002 Nov; 198(3):300-9. PubMed ID: 12375262
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reliable identification of women with CIN3+ using hrHPV genotyping and methylation markers in a cytology-screened referral population.
    Leeman A; Del Pino M; Marimon L; Torné A; Ordi J; Ter Harmsel B; Meijer CJLM; Jenkins D; Van Kemenade FJ; Quint WGV
    Int J Cancer; 2019 Jan; 144(1):160-168. PubMed ID: 30098013
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CyclinA1 Promoter Methylation in Self-Sampling Test.
    Oranratanaphan S; Kengsakul M; Triratanachat S; Kitkumthorn N; Mutirangura A; Termrungruanglert W
    Asian Pac J Cancer Prev; 2020 Oct; 21(10):2913-2917. PubMed ID: 33112548
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Type-dependent association between risk of cervical intraepithelial neoplasia and viral load of oncogenic human papillomavirus types other than types 16 and 18.
    Fu Xi L; Schiffman M; Ke Y; Hughes JP; Galloway DA; He Z; Hulbert A; Winer RL; Koutsky LA; Kiviat NB
    Int J Cancer; 2017 Apr; 140(8):1747-1756. PubMed ID: 28052328
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The impact of age and high-risk human papillomavirus (hrHPV) status on the prevalence of high-grade cervical intraepithelial neoplasia (CIN2+) in women with persistent hrHPV-positive, cytology-negative screening samples: a prospective cohort study.
    Tidy JA; Lyon R; Ellis K; Macdonald M; Palmer JE
    BJOG; 2020 Sep; 127(10):1260-1267. PubMed ID: 32279427
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.